Subsequent, in vitro studies demonstrated that IFNγ treatment can enhance HIV-1 infection in both primary macrophages and CD4+ T cells (33–35), suggesting that these immune cell subsets were responsible for the original observation of HIV-1 infection of PBMC. This evidence concerns the gene CD4 and HIV-1 infection.